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tant determinant of the mucosal response. In patients with in-
ﬂammatory bowel diseases, the mucosal immune system has
inappropriate interactions with the intestinal microbiota. We
investigated how the composition of the intestinal microbiota af-
fects its endotoxicity and development of colitis in mice.
METHODS: Germ-free C57BL/6J-Rag1tm1Mom (Rag1/) mice
were colonized with 2 different types of complex intestinal
microbiota. Colitis was induced in Rag1/ mice by transfer of
CD4þCD62Lþ T cells from C57BL/6J mice. Colonic tissues were
collected and used for histologic analysis and cell isolation. Acti-
vationof laminapropriadendritic cells andT cellswas analyzedby
ﬂow cytometry. RESULTS: After transfer of CD4þCD62Lþ T cells,
mice with intestinal Endolo microbiota (a low proportion of
Enterobacteriaceae, high proportion of Bacteroidetes, and low
endotoxicity)maintainedmucosal immune homeostasis, andmice
with highly endotoxic Endohi microbiota (a high proportion of
Enterobacteriaceae and low proportion of Bacteroidetes) devel-
opedcolitis.Todeterminewhether theeffects ofEndohimicrobiota
were related to the higher endotoxic activity of lipopolysaccharide
(LPS), we compared LPS from Enterobacteriaceae with that of
Bacteroidetes. Administration of Escherichia coli JM83 (wild-type
LPS) to the mice exacerbated colitis, and Escherichia coli JM83 þ
htrBPG (mutated LPS, with lower endotoxicity, similar to that of
Bacteroidetes) prevented development of colitis after transfer of
the T cells to mice. CONCLUSIONS: The endotoxicity of LPS pro-
duced by the intestinal microbiota is a determinant of whether
mice develop colitis after transfer of CD4þCD62Lþ T cells. This
ﬁndingmight aid thedesignofnovelbiologics orprobiotics to treat
inﬂammatory bowel disease.
Keywords: Mouse Model; IBD; Prevention; Bacteria.
he mammalian gastrointestinal tract harbors a dense© 2014 by the AGA Institute
0016-5085
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Tand diverse community of an estimated 10100
trillion micro-organisms1–3 consisting of 5001000 diff-
erent species, of which the vast majority are bacteria.2,4 It iswell accepted that in inﬂammatory bowel disease (IBD), the
mucosal immune system reacts inappropriately toward the
commensal microbiota.5 No particular microbial species has
been consistently linked to IBD pathogenesis or prevention;
however, some symbiotic bacterial species have been shown
to prevent inﬂammatory host responses.2,6–9
Numerous animal models have been generated to
experimentally investigate human IBD,10 including erosive
models of acute colitis (eg, dextran sodium sulfate [DSS]-
induced colitis), spontaneous models of chronic colonic,
and/or small bowel inﬂammation induced by targeted gene
deletion (eg, interleukin [IL]10/ mice) or induction by
disruption of T-cell homeostasis (eg, Rag1/ mice).10 As
chronic colitis results from a dysregulated immune
response to components of the normal intestinal microbiota,
it is reasonable to suggest that the T-celldependent
models are signiﬁcantly more relevant to human disease
than are the erosive models of acute colitis, if one wishes to
investigate the immunologic mechanisms inducing, perpet-
uating, or preventing chronic colitis.10 Microbe-associated
molecular pattern, such as lipopolysaccharide (LPS) or ﬂa-
gellins, are recognized by different pattern recognition re-
ceptors. However, there is a dichotomic role for Toll-like
receptor (TLR) in intestinal inﬂammation.11 For example,
IL2/ MyD88/ mice develop colitis independent of TLR
signaling, and IL10/ MyD88/ mice remain healthy,
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dependent TLR.12 Additionally, in the DSS model of acute
inﬂammation, which is based on disruption of tight junction
proteins and severe disturbance of the intestinal barrier, the
depletion of the intestinal microbiota through antibiotics
resulted in aggravation of acute colitis, which was amelio-
rated by feeding of LPS.13 In the Crohn’s diseaselike mu-
rine T-cellinduced chronic colitis, the roles of LPS and of
pattern recognition receptor signaling remain unclear.
The goal of our study was to show the inﬂuence of
qualitatively different TLR4 signals on development of
chronic T-celldriven colitis. We demonstrate that the
endotoxicity of the intestinal microbiota given by the
composition of the intestinal bacterial communities de-
termines either the maintenance of intestinal homeostasis
or the induction of colitis in genetically predisposed hosts.
Importantly, T-celltransferred Rag1/ mice, with low
endotoxic microbiota due to a high number of bacteria of
the anaerobic Bacteroidetes group, were protected from
induction of transfer colitis, and Rag1/ mice, with high
endotoxic microbiota due to a high number of commensal
Enterobacteriaceae, develop colitis. The low endotoxic
Escherichia coli JM83 þhtrBPg strain (E coliMUT) with alter-
ations in the acylation pattern promoted intestinal homeo-
stasis, and feeding with the high endotoxic E coli JM83 K-12
wild-type (E coliWT) stain resulted in severe intestinal
inﬂammation. This was, in particular, supported by feeding
experiments with isolated LPS from both the WT and
mutant (MUT) strain.
The current results shed new light on the previously
unrecognized role of LPS toxicity in the maintenance of in-
testinal immune homeostasis and suggest novel treatment
options to shape mucosal immunity in patients with IBD.Material and Methods
Mice
For the experiments, inbred C57BL/6J mice and C57BL/6J-
Rag1tm1Mom (Rag1/)14 mice were used. Germ-free mice were
colonized with different complex intestinal microbiota by co-
housing with Endolo or Endohi colonized C57BL/6mice bred and
kept in isolated ventilated cages. Mice were free of Helicobacter
hepaticus, norovirus, and rotavirus. Endolo mice harbor micro-
biota with a high proportion of Bacteroidetes and low proportion
of Enterobacteriaceae, and Endohi Rag1/ mice harbor a high
proportion of Enterobacteriaceae and low proportion of Bac-
teroidetes. Rag1/mice were transplanted with 5 105 splenic
CD4þCD62Lþ T cells at 810 weeks of age.15–20 Endohi Rag1/
mice were analyzed after manifestation of colitis 46 weeks
after T-cell transfer, Endolo Rag1/ mice 6 weeks after T-cell
transfer. All animal experiments were reviewed and approved
by the responsible Institutional Review Board.Growth of Bacteria, Isolation of LPS, and
Analytical Methods
E coli strains (E coli JM83 [E coliWT] and E coli JM83
þhtrBPg [E coliMUT]21) were grown in Luria Bertani medium
until log phase. Where indicated, 100 mg/mL ampicillin andisopropyl-b-D-thiogalactopyranoside (1 mM) was added. The
LPS were extracted according to Galanos et al,22 in the yields of
2.6% (WT) and 2.9% (MUT). Fatty acid analyses23 and high-
resolution electrospray ionization Fourier transform ion
cyclotron mass spectrometry24 were performed as published.
Mice were challenged with 108 viable bacteria or with 160 mg
puriﬁed LPS (6.4 mg/g mouse).
See the Supplementary Materials for information on cell
culture experiments, analysis of fecal samples by culture
methods and quantitative polymerase chain reaction, isolation
of DNA from fecal samples, preparation of amplicon pool and
454-sequencing, bioinformatic analysis, isolation of lp dendritic
(DC) and T cells, intracellular cytokine staining, ﬂow cytometry,
histology, and statistics.
Results
Low Endotoxicity of the Intestinal Microbiota
in Rag1/ Mice Is Associated With Mucosal
Immune Homeostasis
In amodel of IBD,we investigatedwhether the endotoxicity
of complex intestinal microbiota inﬂuenced the incidence or
severity of colitis. Therefore, Rag1/ mice, raised in a germ-
free facility, were colonized with 2 types of complex
intestinal microbiota with different endotoxicity. We used
microbiota with a low TLR4-activating effect (Endolo)
(Figure 1A) characterized by low numbers of Enter-
obacteriaceae (including E coli) and high numbers of Bacter-
oidetes (including Bacteroides vulgatus or Porphyromonas sp)
(Figure 1B and C) and, in addition, a high TLR4-activating
microbiota (Endohi) (Figure 1A) characterized by high
numbers of Enterobacteriaceae and low numbers of Bacter-
oidetes as revealed by culture techniques (Figure 1B) and
quantitative polymerase chain reaction (Figure1C). Analysis of
the intestinal microbiota by 454 sequencing of the 16S ribo-
somal DNA (rDNA) amplicons containing the variable regions
V3V6 revealed 70.3% of Bacteroidetes and 22.94% of Fir-
micutes in the EndoloRag1/mice. Proteobacterial (including
E coli) 16S rDNA amplicons were below the detection limit. In
Endohi Rag1/ mice, 0.19% of the analyzed 16S rDNA
amplicons belonged to Proteobacteria (Enterobacteriaceae,
including E coli, are a family within this phylum), 32.42% to
Bacteroidetes and 61.84% to Firmicutes (including, eg, the
classes Bacilli with the order of Bacillales and Lactobacillales,
Clostridia, or Erysipelotrichia) (Figure 1D). All mice described
in this study were raised in these colonies to assure early peri-
natal colonization with the complex microbiota deﬁned here.
On transfer of T cells from healthy speciﬁc pathogen-free
C57BL/6 mice the Endohi Rag1/ mice developed severe
colitis within 6 weeks, lost signiﬁcant amounts of weight,
and exhibited pronounced inﬂammation of colonic mucosa
and submucosa. In contrast, T-celltransferred Endolo
Rag1/ mice remained healthy for 6 weeks, as indicated by
both weight gain during the course of the experiment and
missing histologic signs of inﬂammation (Figure 2AC).
DCs in the colonic lamina propria (clp) of
T-celltransferred Endohi Rag1/ mice showed signiﬁ-
cantly higher expression of major histocompatibility com-
plex (MHC) class II and CD40 as compared with the lp DC
Figure 1. Endolo and Endohi microbiota exhibit differences in the endotoxicity and composition. Fecal samples from Endolo or
Endohi Rag1/ mice were collected and analyzed by stimulation of TLR4-overexpressing cells, culturing methods, quanti-
tative reverse transcription polymerase chain reaction (RT-PCR) analysis and 454 sequencing before T-cell transfer. (A)
Concentrations of IL-8 in supernatants of feces stimulated TLR4-transfected HEK293 cells. Data are means of 3 independent
experiments (SEM), statistical analyses were performed using analysis of variance with Bonferroni’s post test. (B) Serial
dilutions of fresh fecal homogenates were plated on optimal and selective agar plates and incubated under anaerobic and
aerobic conditions. The colony-forming units (CFU) per plate were counted and expressed as log10 CFU/g feces; detection
limit 50 CFU; (n  5 mice per group). (C) Fecal samples were analyzed by quantitative RT-PCR; (n  5). (D) Relative abundance
of phyla of intestinal bacteria. Fecal samples were analyzed via 454 sequencing of the 16S rDNA amplicons; (n  5 mice per
group). All statistical analyses were performed using Student t test. ***P < .001.
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Figure 2. T-cellinduced colitis depends on the endotoxicity and composition of intestinal microbiota. Endolo and Endohi
Rag1/mice were transferred with CD4þCD62Lþ T cells. (A) The body weight was monitored weekly and the mean percent of
loss of body weight (SD) was calculated; (n  6). (B) Representative H&E-stained colonic sections. Scale bar ¼ 100 mm (n 
15). (C) Colon histology score. Colon sections were scored blinded. Each symbol represents 1 animal. (D) Percentage of
CD11cþ, CD11cþMHCIIþ, and CD11cþCD40þ cells in the clp (SD) (n  9). (E) T-cell repopulation in clp (SD) (n  20). (F)
Intracellular cytokine and FoxP3 expression in clp CD4þCD3þ T-cells (SD) (n  9). All statistical analyses were performed
using Student t test. *P < .05; ***P < .001.
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mation was associated with a signiﬁcant increase in
CD4þCD3þ T cells in the clp as compared with healthy T-
celltransferred Endolo Rag1/ mice (Figure 2E). This
corresponded to the total numbers of clp T cells (Figure 2E).
Additionally, clp T cells from diseased Endohi Rag1/
mice produced signiﬁcantly more interferon gamma and
IL-17a than T-cells from healthy Endolo Rag1/ mice.
However, there was no signiﬁcant difference in the per-
centage of FoxP3þ regulatory T cells (Figure 2F). The ab-
solute number of T cells differed signiﬁcantly due to the
higher total amount of T cells present in Endohi Rag1/
mice (Supplementary Table 1).These observations suggest that the endotoxicity and
composition of the intestinal microbiota are crucial for
maintaining the mucosal immune homeostasis or induce
inﬂammation. Endolo microbiota promotes intestinal im-
mune homeostasis and Endohi microbiota results in a TH1/
TH17a-driven colitis in Rag1
/ mice after the adoptive
transfer of naïve T cells.Structure of LPS Is Essential for Colitogenicity
of E coli
Variations in the biologic activity of LPS from various
organisms have been ascribed to differences in the structure
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different LPS structures might account for differences in the
anti- or pro-inﬂammatory potential of Endolo and Endohi
microbiota. Therefore, we used a commensal E coli JM83
K-12 (E coliWT) WT strain and a MUT strain, E coli JM83 þ
htrBPg (E coliMUT), which had been published to contain in
the lipid A the fatty acid 16:0 instead of 12:0.21 In a previous
study, this minor lipid A modiﬁcation signiﬁcantly affected
host cell signalling.21
We isolated and puriﬁed LPS from both E coliWT and E
coliMUT and characterized its fatty acid composition; both
contained the typical E coli LPS fatty acids, however, strain E
coliMUT possessed additional 16:0. Additional investigations
by high-resolution electrospray ionization Fourier trans-
form ion cyclotron mass spectrometry proved the presence
of the same hexa-acetylated lipid A molecules in both strains
(Supplementary Figure 1). In addition, E coliMUT contained a
major portion of lipid A, in which 12:0 had been exchanged
to 16:0.
To verify the altered stimulatory capacity of LPSMUT
compared with LPSWT, we used TLR4-overexpressing hu-
man embryonic kidney cells (HEK293). Stimulation of cells
with the modiﬁed LPSMUT resulted in a signiﬁcantly reduced
IL-8 secretion 4 hours after stimulation, as compared with
LPSWT (Figure 3A).
To investigate whether E coliMUT and E coliWT actually
contribute to mucosal immune homeostasis or colitis in our
model, Endolo mice were pretreated with metronidazole and
Endohi mice with streptomycin, and then fed with E coliWT.
Streptomycin was administered to suppress putative col-
itogenic Enterobacteriaceae and to reduce endogenous E coli
to permit colonization of administered E coliWT. Metroni-
dazole was administered to disrupt the endogenous
possibly protective bacteria of the phylum of Bacteroidetes
and to assess the anti-inﬂammatory effect of E coliMUT
(Supplementary Figure 2). As indicated in Figure 3B and C,
Endolo and Endohi Rag1/ mice treated with E coliWT
developed disease upon T-cell transfer and showed high
colony-forming units of Enterobacteriaceae (Supplementary
Figure 3). Histology revealed that T-celltransferred Endolo
and Endohi Rag1/ mice treated with E coliWT showed
inﬂammation of mucosa and submucosa and signiﬁcantly
enhanced histologic score (Figure 3B and C).
In contrast, metronidazole-conditioned E coliMUT-treated
Endolo or streptomycin-conditioned E coliMUT-treated
Endohi Rag1/ mice did not develop colitis, although in
Endolo Rag1/ mice, the application of metronidazole
reduced the number of protective endogenous Bacteroidetes
(Supplementary Figure 3). More strikingly, treatment of
Endohi Rag1/ mice with E coliMUT resulted in protection
from disease (Figure 3B and C), although these animals
harbored high colony-forming units of Enterobacteriaceae in
their feces (Supplementary Figure 3). As a control, we
treated Rag1/ mice with only streptomycin or metroni-
dazole before T-cell transfer. Upon T-cell transfer,
streptomycin-treated Endohi Rag1/ mice developed se-
vere colitis, and metronidazole-treated Endolo Rag1/mice
did not (Supplementary Figure 4). Based on these data, weconclude that the observed effect is a result of treatment
with bacteria, but not the administration of antibiotics.
The relative abundance of phyla in the E coliWT and
E coliMUT treated Endo
lo or Endohi Rag1/ mice was
determined by 454 16S rDNA amplicon sequencing
(Supplementary Figure 5, Supplementary Table 2).
As expected, the treatment of Endolo or Endohi Rag1/
mice with E coliMUT resulted in decreased expression of lp
DC MHC class II and CD40 as compared with E coliWT
(Figure 3D).
T-cell numbers in the lp of metronidazole-treated,
E coliWT-fed Endo
lo Rag1/ mice were signiﬁcantly higher
compared with metronidazole-treated, E coliMUT-fed Endo
lo
Rag1/mice, which did not show accumulation of T cells in
the clp (Figure 3E). This was in line with the total numbers
of lp T cells (Figure 3E).
In streptomycin-treated, E coliWT-fed Endo
hi Rag1/
mice, the percentage of T cells was increased signiﬁcantly,
and treatment with streptomycin plus E coliMUT resulted in a
signiﬁcant reduction in lp T-cell frequency (Figure 3E),
which could also be seen for the total numbers of lp T cells
(Figure 3E).
Lamina propria T cells from E coliWT-treated Endo
lo
Rag1/ mice produced signiﬁcantly less interferon gamma
than E coliMUT-treated Endo
lo Rag1/ mice, although the
IL-17a production did not differ. Strikingly, Endolo Rag1/
mice administered with E coliMUT had signiﬁcantly more
FoxP3þ lp T cells as compared with E coliWT-treated Endo
lo
Rag1/ mice (Figure 3F). Interferon gamma and IL-17a
secretions were similar in E coliWT-treated and E coliMUT-
treated Endohi.
Rag1/ Mice
Again administration of E coliMUT resulted in a signiﬁ-
cantly increased expression of FoxP3 in Endohi Rag1/
mice, as compared with E coliWT-feeding (Figure 3F).
From these results, we conclude that administration of E
coliWT or E coliMUT, thereby shifting the intestinal micro-
biota, is associated with altered activation and maturation of
DC and a change in the T-cell polarization pattern.
Depending on the change in the endotoxicity and composi-
tion (Endolo vs Endohi), the intestinal microbiota might
promote intestinal homeostasis or trigger inﬂammation.
Feeding of LPSMUT Promotes Mucosal
Immune Homeostasis
Up to this point, we demonstrated that the differences in
the LPS of E coli were essential for the ability of E coli to
induce or prevent colitis, as shown by feeding experiments
with E coliWT inducing inﬂammation and E coliMUT pre-
venting disease. To demonstrate conclusively that LPS of E
coliWT and E coliMUT mediated the pro- or anti-inﬂammatory
effect, we investigated whether the feeding of puriﬁed WT
LPS from E coliWT (LPSWT) or mutant LPS (LPSMUT) from E
coliMUT could conﬁrm these results (Supplementary
Figure 2). Therefore, we challenged Endolo and Endohi
Rag1/ mice with puriﬁed LPSWT or LPSMUT.
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with LPSMUT, resulted in induction of colonic inﬂammation
(Figure 4A), as indicated by an increased histology score
(Figure 4B). In addition, LPSWT-fed Endo
hi Rag1/ mice
showed increased colonic inﬂammation as compared with
LPSMUT-treated Endo
hi Rag1/ mice (Figure 4A and B). The
histology of the inﬂamed mucosa resembled the pathology
of Endohi mice (Figure 2B and C). Doseresponse experi-
ments clearly demonstrated that the protection of Endohi
mice from inﬂammation followed a LPSMUT dose response
(Supplementary Figure 6).
The relative abundance of phyla in intestinal microbiota
of LPSWT- and LPSMUT-treated Endo
lo or Endohi Rag1/
mice was determined (Supplementary Figure 7,
Supplementary Table 3) by 454 sequencing of the 16S rDNA
amplicons. However, it remains unclear whether the
changes in the composition of the microbiota due to
administration of LPS are a cause or consequence of the
altered host immune response along with the development
of colitis, and whether this change is an epiphenomenon or
shows a causal effect.
Feeding LPSWT to Endo
lo Rag1/ mice resulted in
signiﬁcantly more activated lp DC in terms of CD40 and MHC
class II expression as compared with LPSMUT-treated Endo
lo
Rag1/ mice (Figure 4C). Lamina propria DC of LPSMUT-
treated Endohi Rag1/ mice showed signiﬁcantly lower ex-
pressions of CD40 than LPSWT-treated Endo
hi Rag1/ mice
and comparable low amounts of MHC class II (Figure 4C).
Feeding LPSWT to Endo
lo Rag1/ mice resulted in signiﬁ-
cantly more lp CD4þ T cells as compared with treatment with
LPSMUT (Figure 4D). Total numbers of lp T cells of LPSWT-
treated EndoloRag1/micewere signiﬁcantly higher than in
LPSMUT-treated Endo
lo Rag1/ mice (Figure 4D). In LPSWT-
treated Endohi Rag1/mice, the number of CD4þ T cells was
signiﬁcantly increased. In line with histologic scoring, the
absence of colitis in LPSMUT-treated Endo
hiRag1/micewas
associated with a signiﬁcantly decreased frequency of lp T
cells (Figure 4D). This was consistent with the total numbers
of lp T cells (Figure 4D).
Interferon gamma and IL-17a production in lp T cells of
LPSWT-treated Endo
lo Rag1/ mice was signiﬁcantly higher
as compared with LPSMUT-treated Endo
lo Rag1/ mice; no
signiﬁcant difference in expression of FoxP3 could be
observed (Figure 4E). Lamina propria T cells of LPSWT-
treated Endohi Rag1/ mice showed signiﬁcantly higher
expression of interferon gamma and IL-17a as compared
with LPSMUT-treated Endo
hi Rag1/ mice. However, no
signiﬁcant differences in FoxP3 expression of lp T cells was
observed (Figure 4E).=
Figure 3. Structure of LPS is essential for colitis induction, DC,
with different concentrations of E coliWT LPS (LPSWT) or E coliMU
supernatants were measured 4 hours after stimulation. Data are
were conditioned with metronidazole, Endohi mice with streptom
naïve CD4þCD62LþT cells were transferred. Representative H&
Colon histology score. Colonic sections were scored blinded. Ea
CD11cþMHCIIþ, and CD11cþCD40þ cells (SD) (n  7). (E) T-c
and FoxP3 expression in clp CD4þCD3þ T cells (SD) (n  7). A
***P < .001; *P < .05.In summary, these data show that changes in the lipid A
structure can convert a pro-inﬂammatory E coli strain into
an anti-inﬂammatory E coli strain, and that the proportion of
LPS with different lipid A structures within the intestinal
microbiota might have a critical inﬂuence on development
of colitis in a genetically predisposed host in the context of a
speciﬁc microbiota.Discussion
Recent studies have examined the function of the in-
testinal microbiota in the pathogenesis of inﬂammatory in-
testinal diseases in genetically predisposed hosts and the
prospects of preventing inﬂammation by selective alteration
of the intestinal microbiota.26–29
We identiﬁed LPS as a microbial factor that, according to
its composition/structure, can either promote or prevent the
development of bowel inﬂammation in the CD4þ T-cell
transfer model of colitis in Rag1/ mice. We demonstrated
that probably by structural changes in the lipid A, the colito-
genic potential of a commensal E coli strain can not only be
abolished, but also converted into a protective commensal
strain that prevents development of T-cellinduced colitis.
Several animal studies demonstrated that the intestinal
microbiota shapes homeostasis of the intestinal mucosal
immune system,29–34 and that a distinct composition of the
intestinal microbiota is associated with promotion of bowel
inﬂammation.29–31,35 However, it is not yet clear whether a
speciﬁc microbiota composition or a speciﬁc microbial
compound might initiate the inﬂammatory process or
perpetuate the chronic inﬂammation. To clarify this, we
used Rag1/ mice transferred with T cells that develop
colitis in the presence of a speciﬁc complex microbiota or
speciﬁc pathobionts (eg, Helicobacter hepaticus36), but
remain healthy under germ-free conditions.
In our model, we observed that an intestinal microbiota
exhibiting low endotoxicity and harboring a high proportion
of Bacteroidetes (Endolo) was associated with prevention of
T-cellinduced colitis, supporting the idea that low endo-
toxic microbiota or bacteria of the Bacteroidetes group
might inhibit mucosal pro-inﬂammatory host responses. In
contrast, the high endotoxicity and high proportion of
Enterobacteriaceae in Endohi Rag1/ mice was clearly
associated with development of intestinal inﬂammation.
According to the reports with different animal models, such
associations cannot be generalized, but might rather reﬂect
the pathogenesis of different models of disease.30,31,37
The recognition of microbe-associated molecular pat-
terns, such as LPS, which are ubiquitous to all microbes of aand T-cell activation. (A) TLR4-HEK293 cells were stimulated
T LPS (LPSMUT) (0.0010.1 mg/mL) and IL-8 concentrations in
means of 3 independent experiments (SEM). (B) Endolo mice
ycin and fed with 1  108 E coliWT or E coliMUT. After 7 days,
E-stained colonic sections. Scale bar ¼ 100 mm (n  7). (C)
ch symbol represents 1 animal. (D) Percentage of clp CD11cþ,
ell repopulation in clp (SD) (n  7). (F) Intracellular cytokine
ll statistical analysis were performed using the Student t test.
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instructive role in the development of, the adaptive immune
response.38–40 There are several studies describing either a
pro-inﬂammatory or even a protective role for TLR4/
MyD88 signaling pathways in the development of intestinal
inﬂammation.15,41 In IL-10/ mice, induction of colitis
seems to depend completely on intact TLR/MyD88 signaling
pathways, and IL-2/ mice develop colitis, even in the
absence of TLR/MyD88.12 Yet, studies with acute DSS colitis
report on a protective role of TLR/MyD88 signaling, stating
that the recognition of microbe-associated molecular pat-
terns by TLR is required for intestinal homeostasis.13 We,
however, have shown that high endotoxic TLR4 activation is
associated with colitis induction. Because the DSS model of
acute inﬂammation is based on disruption of tight junction
proteins and the intestinal barrier, and the T-cell transfer
model mimics a chronic TH1/TH17-driven colitis, it is un-
clear to what extent results of the 2 models are comparable.
LPS is a lipoglycan or glycolipid located in the outer
membrane of Gram-negative bacteria composed of an
amphipathic lipid A component and, in S-form LPS, by a
polysaccharide comprising the core region and the O anti-
gen.42 It was shown that LPS binding induces the formation
of a receptor multimer complex composed of 2 copies of the
TLR4/MD2/LPS complex.43 Depending on the structure, the
endotoxic activity of lipid A shows marked variation in
different bacteria, for example, the lipid A of Porphyromonas
gingivalis or Bacteroides species is considerably weaker
than that of E coli, resulting in altered immune
responses.44–46 An opinion paper recently suggested that
the TLR4 dimer might undergo conformational changes at
different cellular locations due to environmental factors,
such as pH. Different dimerization modes might, in turn,
lead to recruitment of different sets of adaptors, which
determine signaling output.47
We hypothesized that E colimight cause colitis due to the
acylation pattern of its lipidA. If the acyl-transferase encoding
gene htrB of P gingivalis is also expressed in E coli JM83 WT,
the strain expresses an additional 16:0 in its lipid A.21 This E
coliMUT possesses a reduced ability to activate TLR2/4
expressing HEK293 cells and monocytes, but aWT activity to
stimulate endothelial cells.21 Our compositional and electro-
spray ionization Fourier transform ion cyclotron mass spec-
trometry investigations additionally conﬁrmed this change in
lipid A structure, suggesting that the mutation has changed
the toxicity of the LPS. Nevertheless, our data demonstrate
that the changes in the lipid A of E coli resulted in a decreased
ability to induce colitis in Rag1/mice. Evenmore, E coliMUT
or the isolated LPSMUT, protected Endo
hi mice from devel-
oping colitis.=
Figure 4. Feeding of LPSMUT promotes intestinal homeostasis. E
with streptomycin and fed with 160 mg LPS from E coliWT or E
drinking water during the whole experiment. After 7 days, mice
Representative colonic sections. All sections were stained with
Colonic sections were scored blinded. Each symbol repres
CD11cþMHCIIþ, and CD11cþCD40þ cells in the clp (SD) (n  8
activated cell sorting analysis of intracellular cytokine and FoxP
tistical analysis were performed using Student t test. ***P < .00In a previous work, we reported that low or high con-
centrations of LPS induce differential DC activation and
maturation resulting in differential T-cell activation and po-
larization.48 Here we show that the expression of activation
and maturation markers of lp DC signiﬁcantly differs in
Endohi and Endolo Rag1/ mice, in E coliMUT or E coliWT and
in LPSWT or LPSMUT challenged mice, respectively, according
to our in vitro studies. Consistent with this, we found
increased expression of TH1/TH17 cytokines in Endo
hi-, E
coliWT-, and LPSWT-treated Rag1
/ mice, but not in the
Endolo-, E coliMUT-, or LPSMUT-challenged Rag1
/ mice.
Accordingly, treatment of mice with E coliMUT resulted in
increased expression of FoxP3 and treatment with LPSMUT in
a reduced expression of IL-17a in the colonic lp T cells.
The delivery of puriﬁed LPS or LPS by viable bacteria
might result in different LPS availability at different intestinal
and cellular components,49 and can contribute to the differ-
ences in the IL-17a and FoxP3 expression on treatment with
LPS or viable bacteria. However, we cannot rule out that an
additional factor of viable E coli might account for this effect.
Currently, it seems to be highly likely that the intestinal
microbiota plays a critical role in the accumulation and
functional maturation of intestinal regulatory T cells.50 We
demonstrated that commensal bacterial species, depending
on the structure of LPS, can induce or prevent expansion and
polarization of intestinal T cells. However, as discussed by
Chung et al,33 many questions remain about the causes of
differential T-cell response. The differentmaturation states of
lp DCmight be induced directly by the commensal bacteria or
bedue to a secondary effect inducedbydifferences in the local
chemokine and cytokine milieu, possibly resulting in a dif-
ference in the downstream T-cell proliferation.
Both the administration of bacteria (E coliWT and E
coliMUT) and treatment with LPSWT or LPSMUT resulted in
alterations in the composition of the intestinal microbiota.
Analysis of the intestinal microbiota by deep sequencing
techniques implies that phylogenetic groups of bacteria
like Firmucutes or Verrucomicrobia might also be involved
in the regulation of the intestinal immune homeostasis.
However, additional functional studies need to clarify the
biologic relevance of this ﬁnding and whether the shift of
the intestinal microbiota by LPS administration is a direct
effect, or represents a secondary effect due to changes in
the local environment in terms of, for example, nutrition,
altered cytokine and chemokine patterns, or induction of
defensins. In addition, an inﬂuence of the altered intestinal
microbiota, and therefore the modiﬁed endotoxicity of the
intestinal microbiota on the maintenance of intestinal ho-
meostasis or induction of inﬂammation, would be
conceivable.ndolo mice were conditioned with metronidazole, Endohi mice
coliMUT once by oral gavage and received 60 mg/mL LPS in
were transferred with 5  105 naïve CD4þ CD62Lþ T cells. (A)
H&E. Scale bar ¼ 100 mm (n  8). (B) Colon histology score.
ents 1 animal (n  8). (C) Percentage of CD11cþ cells,
). (D) T-cell repopulation in lp (SD) (n  8). (E) Fluorescence-
3 expression in lp CD4þCD3þ T cells (SD) (n  8). All sta-
1; *P < .05.
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BASIC
AND
TRANSLATIONAL
ATOur data suggest that the ratio of high endotoxic and low
endotoxic LPS is crucial for the regulation of the intestinal
immune balance. A predominance of high endotoxic LPS
might promote a TH1/TH17 response, subsequently support-
ing intestinal inﬂammation, and a predominance of low
endotoxic LPS might induce an altered activation of the innate
immune system, resulting in DC semi-maturation and either
induction of regulatory T cells or prevention of a TH1/TH17
response, associated with intestinal immune homeostasis.
Zwitterionic polysaccharide A of Bacteroides fragilis has been
identiﬁed as a microbial symbiosis factor acting on the
adaptive immune system.32,51 We propose LPS as a key mi-
crobial symbiosis factor that, depending on its structure, can
induce or prevent bowel inﬂammation by shaping the innate
immunity via TLR4-dependent signalling mechanisms.52
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